Displaying 1 - 1 of 1
Active Ingredient MYCOPHENOLATE
Therapeutic Class IMMUNOSUPPRESSIVE AGENTS
Indications Prophylaxis of acute renal, cardiac, or hepatic transplant rejection.
Caution Taste disturbance, gingival hyperplasia anorexia, weight loss, vomiting, abdominal pain, gastro-intestinal inflammation, ulceration, and bleeding. Patients should undergo regular blood counts; if ne More ...
Dose Range Adult: Cardiac transp lantation: 1.5 g twice daily starting within 5
day s of tansp lantation. Renal: 1 g twice daily , to be started within 72 hours of transp lantation.
Drug Interactions
Pregnancy
Breast Feeding